Betalt samarbete

Medirätts aktieägare slipper “julutspädning”

December 16, 2018

Carl Johan Merner, Medirätt

Related Interviews

Idogen förbereder organisationen inför klinisk prövning

Sensec svarar på frågor om delårsrapporten

Sensec kommenterar status inom affärsområdet Defence

Abelco beskriver tiden som varit och talar om framtiden

Sensec kommenterar status kring arbetet med förvärv

Bayn Europe kommenterar förvärvet av Tweek

Share

® 2020 Corfind™. This site should be considered marketing and not investment advice. All investment involves risk and Corfind™ disclaims all responsability for any loss or loss damage to what kind of thing it may be, based on material derived from Corfind™. All site information and materials are copyrighted by Corfind™. All rights reserved. All materials are provided for noncommercial, personal use only on this site and may not be copied, duplicated, altered, or transferred to any website or medium whatsoever. All agreements must be signed by the individual or organizational representative requesting use of copyrighted material and by an authorized officer at Corfind™